REJUVENATE BIO INC SBIR Phase II Award, November 2018

Multi-Purpose Canines (MPCs) are an integral aspect of the US military. The continued expansion and use of these indispensable force multipliers in an intense, ever-changing and complex battlefield requires enhancing their innate capabilities in a timely manner. Additionally, canines have a relatively short life span, and considering the substantial training period that MPCs must undergo, their effective working time is even more limited. Completion of this Phase II study will provide evidence of the translatability of these therapies and prove their ability to enhance canine performance. By overcoming the inherent delays and scaling issues of traditional breeding programs, gene therapies will enable the rapid distribution of performance enhancements to current and future MPCs.